Jnana co-founders Joanne Kotz (L) and Joel Barrish
Roche doubles down on Jnana's drug discovery platform, kicking off second deal with $50M cash — while biotech bags $107M
Whatever Roche has learned about Jnana Therapeutics’ drug discovery platform over the past two years, it’s intrigued enough to set up a second partnership. …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.